J
Joseph L. Izzo
Researcher at University at Buffalo
Publications - 232
Citations - 53804
Joseph L. Izzo is an academic researcher from University at Buffalo. The author has contributed to research in topics: Blood pressure & Systolic hypertension. The author has an hindex of 46, co-authored 229 publications receiving 51755 citations. Previous affiliations of Joseph L. Izzo include Erie County Medical Center & LSU Health Sciences Center New Orleans.
Papers
More filters
Journal ArticleDOI
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
Aram V. Chobanian,George L. Bakris,Henry R. Black,William C. Cushman,Lee A. Green,Joseph L. Izzo,Daniel W. Jones,Barry J. Materson,Suzanne Oparil,Jackson T. Wright,Edward J. Roccella +10 more
TL;DR: The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated, and empathy builds trust and is a potent motivator.
Journal ArticleDOI
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Aram V. Chobanian,George L. Bakris,Henry R. Black,William C. Cushman,Lee A. Green,Joseph L. Izzo,Daniel W. Jones,Barry J. Materson,Suzanne Oparil,Jackson T. Wright,Edward J. Roccella +10 more
TL;DR: In those older than age 50, systolic blood pressure of greater than 140 mm Hg is a more important cardiovascular disease (CVD) risk factor than diastolic BP, and hypertension will be controlled only if patients are motivated to stay on their treatment plan.
Journal ArticleDOI
The seventh report of the joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC 7 report
Aram V. Chobanian,George L. Bakris,Henry R. Black,William C. Cushman,Lee A. Green,Joseph L. Izzo,Daniel W. Jones,Barry J. Materson,Suzanne Oparil,J.T. Wright,J. R. Toccella,Edward J. Rocella,Melissa M. Brown +12 more
TL;DR: The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated, and empathy builds trust and is a potent motivator.
Journal ArticleDOI
Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
Clive Rosendorff,Henry R. Black,Christopher P. Cannon,Bernard J. Gersh,Joel M. Gore,Joseph L. Izzo,Norman M Kaplan,Christopher M. O'Connor,Patrick T. O'Gara,Suzanne Oparil +9 more
TL;DR: The optimal choice of antihypertensive agents remains controversial, and there are only partial answers to important questions in the treatment of hypertension in the prevention and management of ischemic heart disease (IHD).
Journal ArticleDOI
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Hermann Haller,Sadayoshi Ito,Joseph L. Izzo,Andrzej Januszewicz,Shigehiro Katayama,Jan Menne,Albert Mimran,Ton J. Rabelink,Eberhard Ritz,Luis M. Ruilope,Lars Christian Rump,Giancarlo Viberti +11 more
TL;DR: Olmesartan was associated with a delayed onset of microalbuminuria, even though blood-pressure control in both groups was excellent according to current standards.